Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese women
Open Access
- 16 December 2009
- journal article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10 (1) , 139
Abstract
Background: Several studies have reported the association of the SNP rs2414096 in the CYP19 gene with hyperandrogenism, which is one of the clinical manifestations of polycystic ovary syndrome (PCOS). These studies suggest that SNP rs2414096 may be involved in the etiopathogenisis of PCOS. To investigate whetherthe CYP19 gene SNP rs2414096 polymorphism is associated with the susceptibility to PCOS, we designed a case-controlled association study including 684 individuals. Methods: A case-controlled association study including 684 individuals (386 PCOS patients and 298 controls) was performed to assess the association of SNP rs2414096 with PCOS. Genotyping of SNP rs2414096 was conducted by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method that was performed on genomic DNA isolated from blood leucocytes. Results were analyzed in respect to clinical test results. Results: The genotypic distributions of rs2414096 (GG, AG, AA) in the CYP19 gene (GG, AG, AA) in women with PCOS (0.363, 0.474, 0.163, respectively) were significantly different from that in controls (0.242, 0.500, 0.258, respectively) (P = 0.001). E2/T was different between the AA and GG genotypes. Age at menarche (AAM) and FSH were also significantly different among the GG, AG, and AA genotypes in women with PCOS (P = 0.0391 and 0.0118, respectively). No differences were observed in body mass index (BMI) and other serum hormone concentrations among the three genotypes, either in the PCOS patients or controls. Conclusions: Our data suggest that SNP rs2414096 in the CYP19 gene is associated with susceptibility to PCOS.Keywords
This publication has 24 references indexed in Scilit:
- Polycystic ovary syndrome and its developmental originsReviews in Endocrine and Metabolic Disorders, 2007
- Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndromeFertility and Sterility, 2006
- CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian womenToxicology Letters, 2006
- Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian femalesHuman Molecular Genetics, 2006
- A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOSMolecular Human Reproduction, 2006
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray AnalysisJournal of Biological Chemistry, 2003
- Polymorphism T→C (−34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndromeFertility and Sterility, 1999
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective StudyThe Journal of Clinical Endocrinology & Metabolism, 1998
- Hypersecretion of androstenedione by isolated thecal cells from polycystic ovariesThe Journal of Clinical Endocrinology & Metabolism, 1994